Our Anesthesia Experiences in Hepatopancreatobiliary Surgery Practices: a Retrospective Study

Launched by SISLI HAMIDIYE ETFAL TRAINING AND RESEARCH HOSPITAL · Aug 16, 2023

Keywords

ClinConnect Summary

This clinical trial is looking into how the way we manage anesthesia (the medicine that keeps patients asleep and pain-free during surgery) impacts patients' recovery after major abdominal surgeries for conditions like liver and pancreatic cancer. Specifically, researchers want to find out if changes in anesthesia techniques have helped patients live longer after surgery and whether these methods have affected how long they need to stay in the hospital.

To be eligible for this study, patients must be between 65 and 74 years old and have had their first surgery for liver cancer, cholangiocarcinoma (a type of bile duct cancer), or pancreatic cancer between October 2017 and February 2022. Those who were unable to have surgery during the procedure or who had multiple surgeries will not be included. If you participate, your past medical records related to your surgery will be reviewed to gather information about your recovery and hospital stay. The findings from this study could help improve care for future patients undergoing similar surgeries.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • The study will include data from patients who have undergone their first operation with the diagnoses of liver malignancy, cholangiocarcinoma, and pancreatic malignancy during the period from October 2017 to February 2022.
• Exclusion Criteria:
• • Data from patients who were deemed inoperable during the perioperative period after being taken into surgery with their current diagnosis, as well as data from patients who underwent repeat operations, were excluded from the study for their second and subsequent hospitalizations.